Additionally, bioinformatics analysis—integrating gene expression data, clinical information, and public glioma databases—allows for the systematic exploration of these complex biological datasets, revealing the involvement of TMED3 in critical biological functions, including tumor cell growth, migration, and resistance to therapy [21–23]. Here, TMED3 is linked to central nervous system cancer.